|
August
1, 2023 |
|
|
|
2023
Prospectus |
| |||
Management
Fees |
Distribution
and
Service
(12b-1)
Fees |
Other
Expenses2
|
Total
Annual
Fund
Operating
Expenses |
|
|
|
|
1
Year |
3
Years |
5
Years |
10
Years |
$ |
$ |
$ |
$ |
|
One
Year |
Five
Years |
Ten
Years |
(Inception
Date: |
|
|
|
Return
Before Taxes |
- |
|
|
Return
After Taxes on Distributions1
|
- |
|
|
Return
After Taxes on Distributions and Sale of Fund
Shares1
|
- |
|
|
Dow
Jones U.S. Select Pharmaceuticals Index
(Index
returns
do not reflect deductions for fees, expenses, or
taxes) |
- |
|
|
|
iShares
U.S. Pharmaceuticals ETF | ||||
|
Year
Ended
03/31/23 |
Year
Ended
03/31/22 |
Year
Ended
03/31/21 |
Year
Ended
03/31/20 |
Year
Ended
03/31/19 |
Net
asset value, beginning of
year |
$194.18 |
$177.38 |
$134.83 |
$154.05 |
$147.20 |
Net
investment income(a)
|
3.07 |
3.06 |
2.20 |
2.14 |
1.73 |
Net
realized and unrealized gain
(loss)(b)
|
(18.22
) |
16.88 |
42.53 |
(19.09
) |
6.91 |
Net
increase (decrease) from
investment
operations |
(15.15
) |
19.94 |
44.73 |
(16.95
) |
8.64 |
Distributions
from net investment
income(c)
|
(3.61
) |
(3.14
) |
(2.18
) |
(2.27
) |
(1.79
) |
Net
asset value, end of year |
$175.42 |
$194.18 |
$177.38 |
$134.83 |
$154.05 |
Total
Return(d) |
|
|
|
|
|
Based
on net asset value |
(7.83
)% |
11.29
% |
33.30
% |
(11.06
)% |
5.88
% |
Ratios
to Average Net Assets(e) |
|
|
|
|
|
Total
expenses |
0.40
% |
0.39
% |
0.42
% |
0.42
% |
0.42
% |
Net
investment income |
1.66
% |
1.63
% |
1.33
% |
1.45
% |
1.12
% |
Supplemental
Data |
|
|
|
|
|
Net
assets, end of year (000) |
$377,159 |
$407,773 |
$354,762 |
$276,404 |
$385,114 |
Portfolio
turnover rate(f)
|
46
% |
20
% |
52
% |
40
% |
51
% |
Call: |
1-800-iShares
or 1-800-474-2737 (toll free)
Monday
through Friday, 8:30 a.m. to 6:30 p.m. (Eastern
time) |
Email: |
|
Write: |
c/o
BlackRock Investments, LLC
1
University Square Drive, Princeton, NJ
08540 |